DEBx Medical
DEBx Medical is a medical technology company dedicated to revolutionizing chronic wound management by providing innovative, easy-to-use treatments that improve patient outcomes worldwide. Their flagship product, DEBRICHEM®, is a topical dehydrating agent that removes infection and biofilm in hard-to-heal wounds within 60 seconds, supporting faster healing and reducing the need for surgical debridement and antibiotics. The company focuses on delivering disruptive wound care solutions, investing in research and development, and expanding its product portfolio to cover all phases of wound care. Headquartered in the Netherlands, DEBx Medical operates globally with a network of dedicated partners and aims to file for FDA approval in 2024.
Industries
Nr. of Employees
small (1-50)
DEBx Medical
Rotterdam, Zuid-Holland, The Netherlands, Europe
Products
Topical acidic desiccant formulation for non-surgical debridement
Topical desiccant intended for non-surgical removal of biofilm and associated microbes in hard-to-heal wounds by rapid desiccation of exposed wound material; described for professional clinical use with a short application dwell time.
Topical acidic desiccant formulation for non-surgical debridement
Topical desiccant intended for non-surgical removal of biofilm and associated microbes in hard-to-heal wounds by rapid desiccation of exposed wound material; described for professional clinical use with a short application dwell time.
Services
On-site clinical demonstrations
Free in-facility demonstrations where clinicians can observe and treat patients using the topical chemical debridement procedure and evaluate clinical workflow integration.
Distributor partnership program
Commercial partnership offering materials, market information and onboarding support for regional distributors to expand product availability.
Educational webinars and video presentations
Recorded presentations, webinars and case-study videos for clinicians covering mechanism of action, clinical cases, procedural guidance and safety on intact skin.
On-site clinical demonstrations
Free in-facility demonstrations where clinicians can observe and treat patients using the topical chemical debridement procedure and evaluate clinical workflow integration.
Distributor partnership program
Commercial partnership offering materials, market information and onboarding support for regional distributors to expand product availability.
Educational webinars and video presentations
Recorded presentations, webinars and case-study videos for clinicians covering mechanism of action, clinical cases, procedural guidance and safety on intact skin.
Expertise Areas
- Topical chemical debridement for chronic wounds
- Biofilm eradication strategies in wound care
- Clinical pathway development for wound management
- Preclinical ex vivo infection modeling and clinical case-series evaluation
Key Technologies
- Topical desiccant formulations
- Biofilm desiccation chemistry (water-binding mechanisms)
- Integration with negative pressure wound therapy (NPWT)
- Ex vivo human explant infection models